Brainstorm Diagnostics News

Dr. Douglas Smith, one of the founders of Brainstorm Diagnostic, LLC, has been awarded an $8 million grant from the US Department of Defense, in part, to expand the potential use of the blood biomarker, SNTF. The award will be pursued at the University of Pennsylvania, where Dr. Smith serves as a professor of neurosurgery. SNTF has previously been shown to identify damage to the brain’s nerve fibers or “axons” in acute concussion, which predicts persisting cognitive impairments. The new award will examine blood SNTF levels in higher levels of traumatic brain injury and how they change over a year after injury in relation to symptom outcomes. This work could identify new diagnostics opportunities for the SNTF assay technology.